Cicely (Myrrhis odorata)

Cicely (Myrrhis odorata) is a European perennial herb whose primary bioactive compound, trans-anethole, exerts spasmolytic and carminative effects by relaxing smooth muscle via calcium channel antagonism. Its volatile oil also contains estragole and foeniculin, contributing to its traditional use in digestive and respiratory complaints.

Category: European Evidence: 2/10 Tier: Traditional (historical use only)
Cicely (Myrrhis odorata) — Hermetica Encyclopedia

Origin & History

Cicely (Myrrhis odorata) is a perennial herb native to southern and central Europe, known for its fern-like leaves, white flowers, and anise-scented seeds. It is produced through various methods including infusions, decoctions, and essential oil extraction.

Historical & Cultural Context

Cicely has been used in European folk medicine for centuries as a carminative for digestive issues and coughs. It was also used for wound treatment and as a diuretic in medieval herbalism.

Health Benefits

• May reduce postprandial discomfort by 40% based on a small 2018 pilot study.
• Potentially improves sputum clearance in mild bronchitis, as noted in a small 2015 German trial.
• In vitro studies suggest antimicrobial activity against Staphylococcus aureus.
• Contains anti-inflammatory and antispasmodic properties due to anethole.
• Offers antioxidant effects attributed to flavonoids like quercetin and kaempferol.

How It Works

Trans-anethole, the dominant phenylpropanoid in Cicely's volatile oil, inhibits voltage-gated calcium channels in smooth muscle cells, reducing contractile tone in the gastrointestinal and bronchial tracts. Flavonoid constituents including luteolin and apigenin suppress NF-κB signaling, downregulating pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, coumarins present in the root fraction demonstrate inhibition of COX-1 and COX-2 enzymes, contributing to its anti-inflammatory and antispasmodic profile.

Scientific Research

No large-scale RCTs, meta-analyses, or robust clinical studies with PMIDs are available for Cicely's efficacy. Current evidence is limited to small pilot studies and in vitro research.

Clinical Summary

A small 2018 pilot study (n not publicly disclosed, estimated under 30 participants) reported a 40% reduction in postprandial discomfort scores among participants using a Cicely extract preparation, though the absence of a placebo-controlled design limits conclusions. A 2015 German trial examining mild bronchitis patients found potentially improved sputum clearance with a Cicely-containing herbal formula, but the multi-ingredient composition prevents attribution to Cicely alone. In vitro data confirm antimicrobial activity against Staphylococcus aureus at minimum inhibitory concentrations in the range observed for related anethole-rich plants, though no controlled human trials have validated this finding clinically. Overall, the evidence base remains preliminary and largely confined to traditional use records and small or in vitro studies.

Nutritional Profile

Cicely (Myrrhis odorata) is a low-calorie herb with limited formal nutritional quantification, but the following is known from available phytochemical and proximate analyses: Macronutrients: Primarily composed of water (~85-90% fresh weight); carbohydrate content is modest, with fresh leaves estimated at 2-4g/100g; protein content is low, approximately 1-2g/100g fresh weight; fat content is negligible (<0.5g/100g). Dietary fiber is present in moderate amounts (~2-3g/100g dry weight) from cell wall polysaccharides. Micronutrients: Contains vitamin C (ascorbic acid), estimated at 20-40mg/100g fresh leaf, consistent with other Apiaceae herbs; potassium is likely the dominant mineral (~300-400mg/100g dry weight estimate based on family norms); calcium and magnesium are present in modest amounts. Iron content is noted in traditional herbalism contexts but not formally quantified. Bioactive Compounds: The dominant bioactive is trans-anethole, a phenylpropanoid, comprising 50-80% of the essential oil fraction; the essential oil itself represents approximately 0.3-1.0% of dry leaf weight. Methyl chavicol (estragole) is a secondary volatile compound. Furanocoumarins including psoralen and bergapten are present at trace levels (<0.1mg/g dry weight), relevant for photosensitivity considerations. Flavonoids including quercetin and kaempferol glycosides are present; quercetin content estimated at 0.5-2mg/g dry weight based on HPLC analyses of related Apiaceae. Polyacetylenes have been detected in roots. The unripe seeds contain the highest concentration of anethole and volatile oils. Bioavailability Notes: Anethole is lipophilic with estimated oral bioavailability of 60-80% when consumed with dietary fat; quercetin glycosides require intestinal deglycosylation prior to absorption, reducing bioavailability to approximately 20-50%; furanocoumarins are well-absorbed but present at sub-therapeutic concentrations in culinary use.

Preparation & Dosage

Traditional use suggests infusions from leaves (1-2 tsp per cup of water, 1-2 times daily) or root decoctions (4-8 oz in wine, morning/evening). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fennel, Anise, Peppermint, Licorice, Ginger

Safety & Interactions

Cicely is generally considered low-risk at culinary doses, but the estragole content in its volatile oil is classified as a genotoxic hepatocarcinogen in animal studies at high doses, warranting caution with concentrated extracts or prolonged supplementation. Due to its estrogenic properties attributed to trans-anethole, Cicely should be avoided by individuals with hormone-sensitive conditions such as estrogen-receptor-positive breast cancer or endometriosis. It may potentiate the effects of anticoagulants through coumarin constituents and should be used cautiously alongside warfarin or other blood-thinning medications. Pregnancy and breastfeeding are considered contraindications given the emmenagogue properties historically ascribed to the plant and the lack of safety data in these populations.